Hydrogen sulfide inhibits Ca(2+)-induced mitochondrial permeability transition pore opening in spontaneously hypertensive rats
Strutyns'ka NA, Dorofeieva NO, Vavilova HL, Sahach VF
O.O. Bogomoletz Institute of Physiology National Academyof Science of Ukraine, Kyiv
DOI: https://doi.org/10.15407/fz59.01.003
Abstract
In experiments in vivo and in vitro on the mitochondria isolated from the control and spontaneously hypertensive rats (SHR) hearts, we studied the effects of a donor of hydrogen sulfide (H2S), NaHS, and H2S biosynthesis substrate, L-cysteine, on the sensitivity of the mitochondrial permeability transition pore (mPTP) opening to its natural inductor, Ca2+. We found that NaHS (10(-4), 10(-5) and 5 10(-5) mol/l) influenced the mitochondrial swelling in a concentration-dependent manner in control and spontaneously hypertensive rats. The H2S donor NaHS used in physiological concentrations (10(-6), 10(-5) and 5 10(-5) mol/l) exerted the inhibiting effect on the Ca(2+)-induced mPTP opening in control hearts (corresponding values of such effect were 31, 76, and 100%, respectively), while in spontaneously hypertensive rats hearts the protector effect of NaHS was observed only at its concentration of 10(-5) - 10(-4) mol/l. In experiments in vivo, single intraperitoneal injections of L-cysteine (10(-3) mol/kg) resulted in a decrease in the sensitivity of mPTP to it's inductor Ca2+ in control rats and SHR. In experiments in vivo in which we used a specific blocker of cystathionine-gamma-lyase, propargylglycine (10(-4) mol/kg), with the further injections of L-cysteine we observed a decrease in the threshold Ca2+ concentration (that induce the mitochondrial swelling) by three orders of magnitude in SHR, but in control rats did not effect of L-cysteine. Thus, both endogenous and exogenous hydrogen sulfide inhibits Ca(2+)-induced mitochondrial permeability transition pore opening, indicating its protective effect on pore formation in spontaneously hypertensive rats hearts. Therefore, our studies are indicative of the involvement of H2S in modulation of changes in the permeability of mitochondrial membranes, which can be an important regulatory factor in the development of cardiovascular diseases.
Keywords:
hydrogen sulfide, L-cysteine, mitochondrial permeabilitytransition pore, heart, hypertension, rats.
References
- Budnikov E.Yu., Postnov A.Yu., Doroshchuk A.D., Afanas'eva G.V., Postnov Yu.V. Snizhennaya ATF-sinteziruyushchaya sposobnost' mitohondrii pecheni spontanno gipertenzivnih kris (SHR): rol' kal'tsievoi peregruzki mitohondrii . Kardiologiya. 2002. N 12. P. 47-50.
- Gorbas' I.M. Epidemiologichni ta mediko-sotsial'ni aspekti arterial'noi gipertenzii . Ukr. kardiol. zhurn. 2010. N 1. P.13-18.
- Dorofeieva N.O., Goshovs'ka Yu.V.,Sagach V.F. Membrannii potentsial mitohondrii sertsya i shvidkist' spozhivannya kisnyu u shchuriv iz genetichno determinovanoyu arterial'noyu gipertenziieyu . Fiziol. zhurn. 2011. 57, N 3 P.3-9.
- Dorofeeva N.A., Sagach V.F. Vliyanie serovodoroda na funktsionirovanie mitohondrii serdtsa spontanno gipertenzivnih kris . Aktual'ni problemi transportnoi meditsini. 2012. N 2(28). P.116-119.
- Dorofeieva N.O., Kuz'menko M.O., Sagach V.F. Vpliv donoru sirkovodnyu na funktsiyu sertsya spontanno gipertenzivnih shchuriv . Tavrich. med. biol. vestn. 2012. N 3, ch.1(59). P.92-94.
- Doroshchuk A.D. Strukturno-funktsional'nie osobennosti mitohondrii pri eksperimental'noi gipertonii razlichnogo geneza: Avtoref. dis. … kand. biol. nauk: M., 2007. 17 p.
- Kovalenko V.M. Talaeva T.V., Bratus' V.V. Znachimost' arterial'noi gipertenzii kak faktora serdechno-sosudistoi patologii, mehanizmi ee proaterogennogo deistviya . Ukr. kardiol. zhurn. 2010. N 3.
- Postnov A.Yu. Nekotorie molekulyarnie i kletochnotkanevie harakteristiki patogeneza arterial'noi gipertenzii: osobennosti nasledovaniya i kletochnoi energetiki (eksperimental'noe issledovanie): Avtoref. dis. d-ra med. nauk. M., 2005. 18 s.
- Postnov Yu.V., Orlov S.N., Budnikov E.Yu., Doroshchuk A.D., Postnov A.Yu. Narushenie preobrazovaniya energii v mitohondriyah kletok s umen'sheniem sinteza ATF kak prichina statsionarnogo povisheniya urovnya sistemnogo arterial'nogo davleniya . Kardiologiya. 2008. N 8. P. 49-59.
- Sagach V.F., Vavilova G.L., Strutins'ka N.A., Rudik O.V. Starinnya pidvishchuie chutlivist' do induktoriv mitohondrial'noi pori v sertsi shchuriv . Fiziol. zhurn. 2004. 50, N 2. P.49-63.
- Semenihina O.M., Bazilyuk O.V., Korkach Yu.P., Sagach V.F. Rol' ta mehanizmi vplivu sirkovodnyu na skorotlivu aktivnist' gladen'kih m'yaziv riznih sudin shchuriv . Tam samo. 2011. 57, N 4 P.3-11.
- Strutins'ka N.A., Semenihina O.M., Chorna S.V., Vavilova G.L., Sagach V.F. Sirkovoden' prignichuie kal'tsiiindukovane vidkrivannya mitohondrial'noi pori u sertsi doroslih i starih shchuriv . Tam samo. 2011. 57, N 6. P.3-14.
- Strutins'ka N.A., Dorofeieva N.O., Vavilova G.L., Sagach V.F. Pidvishchena chutlivist' mitohondrial'noi pori do induktora Sa2+ u sertsi shchuriv zi spontannoyu gipertenziieyu . Tam samo. 2012. N 6. P.
- Shimanskaya T.V., Dobrovol'skii F.V., Vavilova G.L., Strutinskaya N.A., Rudik E.V., Sagach V.F. NO- zavisimaya modulyatsiya chuvstvitel'nosti otkritiya mitohondrial'noi pori pri ishemii-reperfuzii izolirovannogo serdtsa . Ros. fiziol. zhurn. 2009. 95, N 1 P.28-37.
- Aguilera-Aguirre L., Gonzalez-Hernandez J.C., PerezVazquez V., Ramırez J., Clemente-Guerrero M., VillalobosMolina R., Saavedra-Molina A. Role of intramitochondrial nitric oxide in rat heart and kidney during hypertension . Mitochondrion. 2002. P. 413-423.
CrossRef
- Chang L., Geng B., Yu F., Zhao J., Jiang H., Du J, Tang C. Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats . Amino Acids. 2008. 34. P. 573 585.
CrossRef
PubMed
- Junbao D., Hui Y., Chaoshu T. Endogenous H2S in involved in the development of spontaneous hypertension . J. Peking. Univ.[Health Sci.]. 2003. N 35. P.102.
- Li L., Hsu A., Moore P.K. Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation a tale of three gases. Pharmacol. Ther. 2009. 123. P. 386-400.
CrossRef
PubMed
- Lowicka E., Beltowski J. Hydrogen sulfide (H2S) the third gas of interested for pharmacologists . Pharmacol. Rep. 2007. 59. P. 4-24.
PubMed
- Mancardi D., Penna C., Merlino A., Del Soldato P, Wink D.A., Pagliaro P. Physiological and pharmacological featurers of the novel gasotransmitter : hydrogen sulphide . Biochem. Biohys. Acta. 2009. 1787. P. 864-872.
- Skovgaard N, Gouliaev A, Aalling M, Simonsen U. The role of endogenous H2S in cardiovascular physiology . Curr. Pharm. Biotechnol. 2011. 12, N 9. P. 1385-1393.
CrossRef
PubMed
- Whiteman M., Moore P.K. Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability . J. Cell. Mol. Med. 2009. 13. P. 488-507.
CrossRef
PubMed PubMedCentral
- Yang G., Wu L., Jiang B., Yang W., Qi J. N2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine γ-lyase . Science. 2008. 322. P. 587-590.
CrossRef
PubMed PubMedCentral
|